Patents by Inventor Sophie Le Ricousse-Roussanne

Sophie Le Ricousse-Roussanne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8338169
    Abstract: A cell/ligand specific marking system, the system being characterized in that it comprises: (a) an endothelial precursor cell (EPC) including a cell marker selected from among the group consisting of the Eph (in particular EphB4 or EphB1), and (b) a protein material of structure L-K, which consists of a ligand (L) specific of the marker and is associated or fused with a binding protein (K), the system being capable of providing a proangiogenetic cell material of structure EPC-Eph-L-K. The invention also concerns the cell material as product capable of stimulating angiogenesis, its preparation method and its therapeutic use, in particular with respect to vascular insufficiencies.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: December 25, 2012
    Assignees: Institut des Vaisseaux et du Sang, Universite Paris 7-Denis Diderot
    Inventors: Philippe Foubert, Sophie Le Ricousse-Roussanne, Jean-Sebastien Silvestre
  • Publication number: 20100086524
    Abstract: The invention relates to a cellular preparation containing endothelial cell precursors (EPCs) and smooth muscular cell precursors (SMCs), as a combination product for simultaneous, separated or time-spread administration, used as a revascularisation stimulating agent. The invention also relates to the use of such a cellular preparation.
    Type: Application
    Filed: December 6, 2007
    Publication date: April 8, 2010
    Inventors: Gérard Tobelem, Sophie Le Ricousse-Roussanne, Philippe Foubert, Jean-Sébastien Silvestre
  • Publication number: 20090123431
    Abstract: A cell/ligand specific marking system, the system being characterized in that it comprises: (a) an endothelial precursor cell (EPC) including a cell marker selected from among the group consisting of the Eph (in particular EphB4 or EphB1), and (b) a protein material of structure L-K, which consists of a ligand (L) specific of the marker and is associated or fused with a binding protein (K), the system being capable of providing a proangiogenetic cell material of structure EPC-Eph-L-K. The invention also concerns the cell material as product capable of stimulating angiogenesis, its preparation method and its therapeutic use, in particular with respect to vascular insufficiencies.
    Type: Application
    Filed: July 27, 2006
    Publication date: May 14, 2009
    Inventors: Philippe Foubert, Sophie Le Ricousse-Roussanne, Jean-Sebastien Silvestre